First Time Loading...

Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.1155 CHF 0.43% Market Closed
Updated: Apr 29, 2024

Addex Therapeutics Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Addex Therapeutics Ltd
Operating Income Peer Comparison

Comparables:
ADCT
CRSP
BSLN
IDIA
KURN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Addex Therapeutics Ltd
SIX:ADXN
Operating Income
-CHf14.4m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Operating Income
-$166m
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Operating Income
-$222.5m
CAGR 3-Years
14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Operating Income
CHf19.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Operating Income
-CHf803m
CAGR 3-Years
-19%
CAGR 5-Years
-152%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Operating Income
-CHf8.7m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is Addex Therapeutics Ltd's Operating Income?
Operating Income
-14.4m CHF

Based on the financial report for Sep 30, 2023, Addex Therapeutics Ltd's Operating Income amounts to -14.4m CHF.

What is Addex Therapeutics Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
13%

Over the last year, the Operating Income growth was 52%. The average annual Operating Income growth rates for Addex Therapeutics Ltd have been 13% over the past three years .